These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8043891)

  • 1. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.
    Schnack C; Capek M; Banyai M; Kautzky-Willer A; Prager R; Schernthaner G
    Acta Diabetol; 1994 Apr; 31(1):14-8. PubMed ID: 8043891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
    Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus.
    Bilo H; Kluitman E; van Ballegooie E; Potter van Loon BJ; Bakker K; Michels B; Gans R; Donker A
    Diabetes Res; 1993; 23(3):115-22. PubMed ID: 7712685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ; Ramos OL; Gross JL
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study.
    Caramori ML; Gross JL; Pecis M; de Azevedo MJ
    Diabetes Care; 1999 Sep; 22(9):1512-6. PubMed ID: 10480518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
    Parving HH; Tarnow L; Nielsen FS; Rossing P; Mandrup-Poulsen T; Osterby R; Nerup J
    Diabetes Care; 1999 Mar; 22(3):478-83. PubMed ID: 10097932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA; Cowan P; Patrick AW; Clarke BF
    Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal haemodynamics during short-term angiotensin converting enzyme inhibition in normotensive normoalbuminuric insulin dependent diabetics.
    Vora JP; Hendre TJ; Atiea J; Owens DR
    Diabetes Res; 1989 May; 11(1):9-12. PubMed ID: 2695280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes.
    Nielsen S; Hove KY; Dollerup J; Poulsen PL; Christiansen JS; Schmitz O; Mogensen CE
    Diabetes Obes Metab; 2001 Dec; 3(6):463-71. PubMed ID: 11903420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
    Schjoedt KJ; Astrup AS; Persson F; Frandsen E; Boomsma F; Rossing K; Tarnow L; Rossing P; Parving HH
    Diabetologia; 2009 Jan; 52(1):46-9. PubMed ID: 18974967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.